Differential Effects of Progenitor Cell Populations on Left Ventricular Remodeling and Myocardial Neovascularization After Myocardial Infarction

Autor: Marinee Chuah, Stefan Janssens, Christophe Dubois, Lertlak Chaothawee, Jan Bogaert, Desire Collen, Piet Claus, Hilde Gillijns, Witold Streb, Peter Pokreisz, Sara Vandenwijngaert, Olivier Gheysens, Ann Belmans, Frans Van de Werf, Zeger Debyser, Glenn Marsboom, Hélène Dépelteau, Frederik Maes, Erik Verbeken, Thierry VandenDriessche, Xiaoshun Liu, Marijke Pellens
Přispěvatelé: Division of Gene Therapy & Regenerative Medicine, Cell Biology and Histology
Jazyk: angličtina
Rok vydání: 2010
Předmět:
medicine.medical_specialty
Magnetic Resonance Imaging
Cine

Neovascularization
Physiologic

Myocardial Reperfusion
030204 cardiovascular system & hematology
Mesenchymal Stem Cell Transplantation
Endothelial progenitor cell
Neovascularization
03 medical and health sciences
0302 clinical medicine
Internal medicine
Paracrine Communication
medicine
Animals
magnetic resonance imaging
Myocardial infarction
Progenitor cell
Ventricular remodeling
Cells
Cultured

endothelial progenitor cells
030304 developmental biology
left ventricular remodeling
Tube formation
0303 health sciences
Ejection fraction
Ventricular Remodeling
Reverse Transcriptase Polymerase Chain Reaction
business.industry
Mesenchymal Stem Cells
myocardial neovascularization
medicine.disease
Immunohistochemistry
Matrix Metalloproteinases
myocardial infarction
Lac Operon
Heart failure
Cardiology
cell therapy
medicine.symptom
business
Cardiology and Cardiovascular Medicine
Stem Cell Transplantation
Zdroj: Journal of the American College of Cardiology
Journal of the American College of Cardiology; Vol 55
ISSN: 0735-1097
DOI: 10.1016/j.jacc.2009.10.081
Popis: OBJECTIVES: We compared biological repair after acute myocardial infarction (AMI) with selected porcine progenitor cell populations. BACKGROUND: Cell types and mechanisms responsible for myocardial repair after AMI remain uncertain. METHODS: In a blinded, randomized study, we infused autologous late-outgrowth endothelial progenitor cells (EPC) (n = 10, 34 +/- 22 x 10(6) CD29-31-positive, capable of tube formation), allogeneic green fluorescent peptide-labeled mesenchymal stem cells (MSC) (n = 11, 10 +/- 2 x 10(6) CD29-44-90-positive, capable of adipogenic and osteogenic differentiation), or vehicle (CON) (n = 12) in the circumflex artery 1 week after AMI. Systolic function (ejection fraction), left ventricular (LV) end-diastolic and end-systolic volumes, and infarct size were assessed with magnetic resonance imaging at 1 week and 7 weeks. Cell engraftment and vascular density were evaluated on postmortem sections. RESULTS: Recovery of LV ejection fraction from 1 to 7 weeks was similar between groups, but LV remodeling markedly differed with a greater increase of LV end-systolic volume in MSC and CON (+11 +/- 12 ml/m(2) and +7 +/- 8 ml/m(2) vs. -3 +/- 11 ml/m(2) in EPC, respectively, p = 0.04), and a similar trend was noted for LV end-diastolic volume (p = 0.09). After EPC, infarct size decreased more in segments with >50% infarct transmurality (p = 0.02 vs. MSC and CON) and was associated with a greater vascular density (p = 0.01). Late outgrowth EPCs secrete higher levels of the pro-angiogenic placental growth factor (733 [277 to 1,214] pg/10(6) vs. 59 [34 to 88] pg/10(6) cells in MSC, p = 0.03) and incorporate in neovessels in vivo. CONCLUSIONS: Infusion of late-outgrowth EPCs after AMI improves myocardial infarction remodeling via enhanced neovascularization but does not mediate cardiomyogenesis. Endothelial progenitor cell transfer might hold promise for heart failure prevention via pro-angiogenic or paracrine matrix-modulating effects.
Databáze: OpenAIRE